Asthma Clinical Trials
Asthma
Not DisclosedActive
Key Facts
About American Health Research
American Health Research is a private, service-oriented clinical research organization (CRO) site that partners with pharmaceutical companies to conduct Phase I-IV clinical trials. It has built a dedicated facility with on-site diagnostic and laboratory capabilities, focusing on therapeutic areas like COPD, asthma, and Type 2 Diabetes. The company is led by its founder, Dr. Selwyn Spangenthal, and emphasizes regulatory compliance, certified staff, and patient-centric operations to generate reliable data for its sponsors. Its business model is based on service fees from clinical trial management, placing it in the 'Revenue Generating' stage.
View full company profileTherapeutic Areas
Other Asthma Drugs
| Drug | Company | Phase |
|---|---|---|
| Technegas® for Asthma | Cyclomedica | Phase 2 |
| Asthma Candidate | Teva | Phase 3 |
| Montelukast Amorphous Form | Morepen Laboratories | Phase-2 |
| Chitinase Inhibitor | Lead Discovery Siena | Discovery |
| RIG-101 | RIGImmune | Pre-clinical |
| SKB378 | Klus Pharma | Phase 1 |
| Advanced Asthma Products | Polpharma | Not Disclosed |
| Solrikitug | Uniquity Bio | Phase 2 |
| Asthma Trial | Science 37 | Phase 3 |
| CAL-4 | Calyxha Biotechnologies | Preclinical |
| Digital Biomarker for Asthma | electronRx | Early Development |
| Flutiform | KYORIN Pharmaceutical | Marketed |